CompoAtlas

viridian Balanced Zinc Complex (2022.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000117/2022
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
UAB “NEWGLOW vaistinė”
Manufacturer
Viridian International Ltd
Origin
Lietuva
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
1 kapsula dienā
Published pack size
kapsulas pa 479 mg
Published packaging
30 vai 90 kapsulas

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
Cinksminerals ; Cinks ; 15 ; mgZincVitamin or mineral
Varšminerals ; Varš ; 1000 ; μgCuivreVitamin or mineral
Sējas lucernaplants ; Sējas lucerna ; Medicago sativa ; pulveris ; 168 ; mgmedicago sativaPlant
Spirulīnaplants ; Spirulīna ; Spirulina major ; pulveris ; 56 ; mgspirulina majorPlant
Melleneplants ; Mellene ; Vaccinium myrtillus ; pulveris ; 56 ; mgvaccinium myrtillusPlant
Beta-karotīna/karotinoīdu maisījums (A vitamīns 150 μg RE)otherNutrients ; Beta-karotīna/karotinoīdu maisījums (A vitamīns 150 μg RE) ; 900 ; μgNot recognisedRole not identified
199foodAdditives ; 199Not recognisedRole not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Lielbritānija

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Sējas lucerna
    Read the warning, when it applies and the studies cited

    ALFALFA - MEDICAGO SATIVA

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners, birth control medication or hormone therapy (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.

    Do not use if you have a history of systemic lupus erythematosus (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

  • Mellene
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line